Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapy.
Mikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 51, pp. 102888-102888
Closed Access | Times Cited: 20

Showing 20 citing articles:

Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut–brain communications
Li Ge, Shuman Liu, Sha Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Ferroptosis: A New Pathway in the Interaction between Gut Microbiota and Multiple Sclerosis
Junjie Jian, Jun Wei
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models
Εleni Stamoula, Spyridon Siafis, Ioannis Dardalas, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35
Plasma and Visceral Organ Kynurenine Metabolites Correlate in the Multiple Sclerosis Cuprizone Animal Model
Helga Polyák, Zsolt Galla, Cecília Rajda, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 976-976
Open Access
Th17-cells in depression: Implication in multiple sclerosis
Mikhail Melnikov, Anna Lopatina
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
Mikhail Melnikov, Мikhail Pashenkov, Alexey Boyко
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5313-5313
Open Access | Times Cited: 18
Atypical antipsychotics in multiple sclerosis: A review of their in vivo immunomodulatory effects
Εleni Stamoula, Alexandra Ainatzoglou, Vasileios‐Periklis Stamatellos, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 58, pp. 103522-103522
Closed Access | Times Cited: 14
The role of 5-HT2B-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosis
Anastasiya Sviridova, Vladimir Rogovskii, В. С. Кудрин, et al.
Journal of Neuroimmunology (2021) Vol. 356, pp. 577608-577608
Closed Access | Times Cited: 15
Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapy
Mikhail Melnikov, D. S. Kasatkin, Anna Lopatina, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 8
The role of biogenic amines in the modulation of monocytes in autoimmune neuroinflammation
Olga Belousova, Anna Lopatina, U. Sh. Kuzmina, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 78, pp. 104920-104920
Closed Access | Times Cited: 4
Risk Factors for Psychiatric Disorders in Patients with Multiple Sclerosis—A Single-Center Study in the Polish Population
Hubert Mado, Michał Błachut, Anna Szczegielniak, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 376-376
Open Access | Times Cited: 1
Do enteric glial cells play a role in the pathophysiology of major depression?
Ravi Philip Rajkumar
Exploration of neuroscience (2024) Vol. 3, Iss. 2, pp. 156-174
Open Access | Times Cited: 1
5-HTP inhibits eosinophilia via intracellular endothelial 5-HTRs; SNPs in 5-HTRs associate with asthmatic lung function
Matthew T. Walker, Jeffrey Bloodworth, Timothy S Kountz, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 1
Calcitriol protects against reductions in striatal serotonin in rats treated with neurotoxic doses of methamphetamine
Wayne A. Cass, Laura E. Peters
Neurochemistry International (2023) Vol. 169, pp. 105590-105590
Open Access | Times Cited: 3
T Lymphocyte Serotonin 5-HT7 Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients
Flora Reverchon, Colleen Guillard, Lucile Mollet, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2418-2418
Open Access | Times Cited: 4
Pegylated chitosan nanoparticles of fluoxetine enhance cognitive performance and hippocampal brain derived neurotrophic factor levels in a rat model of local demyelination
Masoomeh Dadkhah, Salva Afshari, Tara Samizadegan, et al.
Experimental Gerontology (2024) Vol. 195, pp. 112533-112533
Open Access
The influence of fluoxetine on neuroimmune interaction in multiple sclerosis
Mikhail Melnikov, Anna Lopatina, A A Sviridova, et al.
S S Korsakov Journal of Neurology and Psychiatry (2023) Vol. 123, Iss. 7, pp. 65-65
Closed Access | Times Cited: 1
Blockade of D1-like dopaminergic receptors suppresses Th17-cell function in multiple sclerosis
Mikhail Melnikov, A A Sviridova, Tatiana Solodova, et al.
S S Korsakov Journal of Neurology and Psychiatry (2021) Vol. 121, Iss. 7, pp. 82-82
Closed Access | Times Cited: 1
D1 Receptor Blockade Suppresses the Function of Th-17 Cells in Multiple Sclerosis
Mikhail Melnikov, A A Sviridova, Tatiana Solodova, et al.
Neuroscience and Behavioral Physiology (2022) Vol. 52, Iss. 4, pp. 494-499
Closed Access
Mechanisms of brain protection against autoimmune inflammation
А Ю Волков, Mikhail Melnikov, Alexey Boyко
Neurology neuropsychiatry Psychosomatics (2021) Vol. 13, Iss. 1S, pp. 4-9
Open Access
Page 1

Scroll to top